Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.

Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.

Item
http://www.wikidata.org/entity/Q53805326
Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependentCorrelation between KLK6 expression and the clinicopathological features of glioma.Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patientsDevelopment of a survival prediction model for gastric cancer using serine proteases and their inhibitors.Cellular distribution of human tissue kallikreins: immunohistochemical localization.Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma.Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.α2 Integrin-Dependent Suppression of Pancreatic Adenocarcinoma Cell Invasion Involves Ectodomain Regulation of Kallikrein-Related Peptidase-5.Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications.Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering
P2860

Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.

Item
http://www.wikidata.org/entity/Q53805326
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Prognostic implications of the ...... nd 11 in renal cell carcinoma.
@en
Prognostic implications of the ...... nd 11 in renal cell carcinoma.
@nl
type
label
Prognostic implications of the ...... nd 11 in renal cell carcinoma.
@en
Prognostic implications of the ...... nd 11 in renal cell carcinoma.
@nl
prefLabel
Prognostic implications of the ...... nd 11 in renal cell carcinoma.
@en
Prognostic implications of the ...... nd 11 in renal cell carcinoma.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P356
P1433
P1476
Prognostic implications of the ...... nd 11 in renal cell carcinoma.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921